Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Exelixis, Inc. (NASDAQ:EXEL) Shares Acquired by IBM Retirement Fund
07:26am, Thursday, 22'nd Oct 2020
IBM Retirement Fund raised its position in shares of Exelixis, Inc. (NASDAQ:EXEL) by 29.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Exelixis to Release Third Quarter 2020 Financial Results on Thursday, November 5, 2020
12:00am, Thursday, 22'nd Oct 2020
Exelixis, Inc. (Nasdaq: EXEL) announced today that its third quarter 2020 financial results will be released on Thursday, November 5, 2020 after the m
Oppenheimer Gives a Buy Rating to Exelixis (EXEL) - Markets
12:13am, Wednesday, 21'st Oct 2020
In a report released yesterday, Jay Olson from Oppenheimer assigned a Buy rating to Exelixis (EXEL – Research Report), with
Exelixis (EXEL) Received its Third Buy in a Row - Markets
03:15pm, Monday, 19'th Oct 2020
After Oppenheimer and Piper Sandler gave Exelixis (NASDAQ: EXEL) a Buy rating last month, the company received another Buy, this
Analysts Expect Exelixis, Inc. (NASDAQ:EXEL) Will Post Earnings of $0.05 Per Share
07:06am, Monday, 19'th Oct 2020
Wall Street analysts predict that Exelixis, Inc. (NASDAQ:EXEL) will post earnings per share of $0.05 for the current quarter, Zacks reports. Five analysts have provided estimates for Exelixis’ earni
US FDA Accepts for Priority Review Applications for OPDIVO® in Combination with CABOMETYX® in Advanced Renal Cell Carcinoma
2 Great Stocks to Buy With Just $100 | The Motley Fool
01:12pm, Tuesday, 13'th Oct 2020
$100 can go a long way in the stock market -- if you play your cards right.
3 Safe Stocks for a Coming Market Crash | The Motley Fool
11:49am, Tuesday, 13'th Oct 2020
Look for proven resilience and growth prospects on the horizon.
Pfizer Reports Data, And Other News: The Good, Bad And Ugly Of Biopharma (NYSE:PFE)
08:01am, Sunday, 11'th Oct 2020
Pfizer reports encouraging results for growth hormone deficiency trial. Dexcom collaborates with Lilly for diabetes management program.
Oct 09, 2020 (The Expresswire) --
Global Oncology Apoptosis Modulators Market Research Report offers an in-depth analysis of the market size (revenue),...
Oct 09, 2020 (The Expresswire) --
Global and United States Renal Cell Cacinoma Drugs Market 2020 industry research report gives Advancement strategies and...
Exelixis, Inc. (Nasdaq: EXEL) and Aurigene Discovery Technologies Limited (Aurigene) today disclosed new preclinical data showing that AUR102 has potent...
Exelixis, Inc. (NASDAQ: EXEL) today announced new data that support the ongoing clinical development of XL092, the company’s next-generation oral tyrosine...
Exelixis, Inc. (Nasdaq: EXEL) and Aurigene Discovery Technologies Limited (Aurigene) today disclosed new preclinical data showing that AUR102 has pote
